Ansa Biotechnologies Closes Oversubscribed $68 Million Serie

Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing to Power the Next Era of D

Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage.Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow...

Related Keywords

Patrick Zhang , Daniel Lin Arlow , Sebastian Palluk , Lily Li , Linkedin , Twitter , Humboldt Fund , Microsoft , Ansa Biotechnologies , Northpond Ventures , Blue Water Life Science Advisors , Altitude Life Science Ventures , Fiscus Ventures , Carbon Silicon Ventures , Codon Capital , Mubadala Capital , Fifty Years , Founders Daniel Lin Arlow , Nature Biotechnology ,

© 2025 Vimarsana